Coca-Cola Zero (®) Consumption on Night-call Inpatient Course and Mortality

February 17, 2024 updated by: Kwan Yu Heng, Duke-NUS Graduate Medical School

Coke Zero for the Zero: A Study Examining the Effect of Coke Zero Consumption on Night Call Inpatient Course and Mortality

The purpose of this study is to determine the effect of coke zero consumption by night-call staffs on inpatient admission and mortality, and total sleep duration during the night-call duty. Coke Zero is a soft drink that is widely popular within the medical community, carrying the meaning of "zero", which to some, signifies the minimal level of morbidity and mortality that will occupy the on-call the night staffs.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Previous studies have demonstrated that superstitions among the medical community have been prevalent and staffs regularly engaged in conforming to the superstitions because of their associations with workload, inpatient admissions and mortality. As such, the current study aims to evaluate whether the consumption of Coke Zero has an effects on patient admissions and mortality and the eventfulness of the night-call duties.

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Singapore, Singapore, 169608
        • Singapore General Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

• Doctors on the night-call roster at Singapore General Hospital

Exclusion Criteria

• Other allied health professionals or medical students

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Coke Zero Arm
The participant will be given a Coke Zero before each night-call duty for consumption.
Coca-Cola Zero Sugar drink will be given.
Active Comparator: Coke Arm
The participant will be given a Coke before each night-call duty for consumption.
Coca-Cola drink will be given.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inpatient Mortality
Time Frame: The designated night-call doctor's shift from 5PM to 8AM the next day
For patients assigned under the designated night-call doctor's care
The designated night-call doctor's shift from 5PM to 8AM the next day
Inpatient general ward admission
Time Frame: The designated night-call doctor's shift from 5PM to 8AM the next day
For patients assigned under the designated night-call doctor's care
The designated night-call doctor's shift from 5PM to 8AM the next day
Inpatient High Dependency/Intensive Care Unit Admission
Time Frame: The designated night-call doctor's shift from 5PM to 8AM the next day
For patients assigned under the designated night-call doctor's care
The designated night-call doctor's shift from 5PM to 8AM the next day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hours of sleep during the night-call
Time Frame: The designated night-call doctor's shift from 5PM to 8AM the next day
For the designated night-call doctor's care
The designated night-call doctor's shift from 5PM to 8AM the next day
Hours of shift during the night-call
Time Frame: The designated night-call doctor's shift from 5PM to 8AM the next day
For the designated night-call doctor's care
The designated night-call doctor's shift from 5PM to 8AM the next day
Number of steps walked by the night-call staff during the night-call
Time Frame: The designated night-call doctor's shift from 5PM to 8AM the next day
For the designated night-call doctor's care
The designated night-call doctor's shift from 5PM to 8AM the next day
Level of alertness of the night-call staff after the night-call
Time Frame: The designated night-call doctor's shift from 5PM to 8AM the next day
Measured using the Karolinska Sleepiness Scale and the Epworth Sleepiness Scale
The designated night-call doctor's shift from 5PM to 8AM the next day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu Heng Kwan, MD, PhD, SingHealth Internal Medicine Residency

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2024

Primary Completion (Actual)

February 2, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

November 18, 2023

First Submitted That Met QC Criteria

November 26, 2023

First Posted (Actual)

December 5, 2023

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 17, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is currently no plan to share IPD to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mortality

Clinical Trials on Coke Zero

3
Subscribe